Deletions of the PTEN gene were observed in the CRC data set, mostly in MT-L tumors, making up about 40% of all alterations (1228/3311 specimens with PTEN alterations in the combined FMI + PAD dataset). The gene discussed is PTEN; the disease is cancer.